Multiple births, not heart disease, is biggest IVF health risk

Small weight loss brings big health benefits for obese patients

SGLT2 inhibitors and diabetic ketoacidosis

23 Feb 2016

The European Medicines Agency (EMA) urges healthcare professionals to be aware of signs of diabetic ketoacidosis (DKA) in people with type 2 diabetes who are taking SGLT2 inhibitors.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read